76 related articles for article (PubMed ID: 7503807)
1. Protective effects of calcium channel blockers against free radical-impaired endothelial cell proliferation.
Mak IT; Boehme P; Weglicki WB
Biochem Pharmacol; 1995 Oct; 50(9):1531-4. PubMed ID: 7503807
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide.
Mak IT; Zhang J; Weglicki WB
Pharmacol Res; 2002 Jan; 45(1):27-33. PubMed ID: 11820858
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels.
Mak IT; Boehme P; Weglicki WB
Circ Res; 1992 Jun; 70(6):1099-103. PubMed ID: 1576732
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant activity of calcium channel blocking drugs.
Mak IT; Weglicki WB
Methods Enzymol; 1994; 234():620-30. PubMed ID: 7808338
[No Abstract] [Full Text] [Related]
5. Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil.
Mason RP; Mak IT; Walter MF; Tulenko TN; Mason PE
Biochem Pharmacol; 1998 Jun; 55(11):1843-52. PubMed ID: 9714303
[TBL] [Abstract][Full Text] [Related]
6. Protective mechanisms of Mg-gluconate against oxidative endothelial cytotoxicity.
Mak IT; Komarov AM; Kramer JH; Weglicki WB
Cell Mol Biol (Noisy-le-grand); 2000 Dec; 46(8):1337-44. PubMed ID: 11156479
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.
Sugawara H; Tobise K; Kikuchi K
Hypertens Res; 1996 Dec; 19(4):223-8. PubMed ID: 8986452
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
Rybak ME; Renzulli LA
Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of calcium channel blockers on hydrogen peroxide induced increases in endothelial permeability.
Yamada Y; Yokota M; Furumichi T; Furui H; Yamauchi K; Saito H
Cardiovasc Res; 1990 Dec; 24(12):993-7. PubMed ID: 2097066
[TBL] [Abstract][Full Text] [Related]
11. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
Nègre-Salvayre A; Salvayre R
Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
[TBL] [Abstract][Full Text] [Related]
12. L-type Ca2+ channels are not involved in coronary endothelial Ca2+ influx mechanism responsible for endothelium-dependent relaxation.
Uchida H; Tanaka Y; Ishii K; Nakayama K
Res Commun Mol Pathol Pharmacol; 1999; 104(2):127-44. PubMed ID: 10634306
[TBL] [Abstract][Full Text] [Related]
13. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein.
Dacquet C; Mironneau C; Mironneau J
Br J Pharmacol; 1987 Sep; 92(1):203-11. PubMed ID: 2959345
[TBL] [Abstract][Full Text] [Related]
14. Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells.
Hoffman S; Gopalakrishna R; Gundimeda U; Murata T; Spee C; Ryan SJ; Hinton DR
Exp Eye Res; 1998 Jul; 67(1):45-52. PubMed ID: 9702177
[TBL] [Abstract][Full Text] [Related]
15. Particular sensitivity to calcium channel blockers of the fast inward voltage-dependent sodium current involved in the invasive properties of a metastastic breast cancer cell line.
Roger S; Le Guennec JY; Besson P
Br J Pharmacol; 2004 Feb; 141(4):610-5. PubMed ID: 14744811
[TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
Onoda JM; Nelson KK; Taylor JD; Honn KV
Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
[TBL] [Abstract][Full Text] [Related]
17. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
Nishimura K; Miyawaki N; Yamauchi H; Iso T
Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
[TBL] [Abstract][Full Text] [Related]
18. Effects of calcium entry blockers on contractions evoked by endothelin-1, [Ala3,11]endothelin-1 and [Ala1,15]endothelin-1 in rat isolated aorta.
Topouzis S; Pelton JT; Miller RC
Br J Pharmacol; 1989 Oct; 98(2):669-77. PubMed ID: 2684314
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
Ma B; Prueksaritanont T; Lin JH
Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of verapamil isomers on the proliferation of choroidal endothelial cells.
Hoffmann S; Balthasar S; Friedrichs U; Ehren M; Ryan SJ; Wiedemann P
Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):376-81. PubMed ID: 16088412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
